Takarazuka, Japan

Takao Kiyohara


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Ibaraki, JP (1980)
  • Takarazuka, JP (1980 - 1983)

Company Filing History:


Years Active: 1980-1983

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Takao Kiyohara: Innovator in Antitumor and Immunosuppressive Compounds

Introduction

Takao Kiyohara is a prominent inventor based in Takarazuka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as antitumor agents and immunosuppressants. With a total of 7 patents to his name, Kiyohara's work is recognized for its potential impact on medical treatments.

Latest Patents

One of Kiyohara's latest patents involves the creation of antitumor and immunosuppressive 4-carbamoylimidazolium-5-olate. This patent details compounds that include a variety of substituents, such as mono-substituted benzoyl groups and various functional groups that enhance their therapeutic properties. These compounds are designed to be effective as antitumor agents and immunosuppressants, showcasing Kiyohara's innovative approach to drug development.

Career Highlights

Kiyohara is currently associated with Sumitomo Chemical Company, Limited, where he continues to advance his research and development efforts. His work has not only contributed to the scientific community but has also paved the way for new treatment options in oncology and immunology.

Collaborations

Throughout his career, Kiyohara has collaborated with notable colleagues, including Toshio Atsumi and Tetsutaro Sanjiki. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Takao Kiyohara's contributions to the field of pharmaceuticals, particularly in the development of antitumor and immunosuppressive compounds, highlight his role as a leading inventor. His ongoing work at Sumitomo Chemical Company, Limited, along with his collaborations, continues to influence the landscape of medical research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…